Bulletin 2012/02 - European Patent Office
31.12.2012 • Views
Share Embed Flag

Bulletin 2012/02 - European Patent Office

Bulletin 2012/02 - European Patent Office

Bulletin 2012/02 - European Patent Office

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
application.epo.org

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

START NOW

(A61K) I.1(1)<br />

(51) A61K 9/16 (11) 2 403 481 A1*<br />

A61K 9/20 A61K 31/195<br />

(25) En (26) En<br />

(21) 10708475.8 (22) 05.03.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

AL BA ME RS<br />

(86) US 2010/<strong>02</strong>6427 05.03.2010<br />

(87) WO 2010/1<strong>02</strong>252 2010/36 10.09.2010<br />

(30) 06.03.2009 US 158065 P<br />

(54) • ORALE DOSIERFORMEN MIT EINER<br />

HOHEN LADUNG EINES GABAPENTIN-<br />

PRODRUGS<br />

• ORAL DOSAGE FORMS HAVING A HIGH<br />

LOADING OF A GABAPENTIN PRODRUG<br />

• FORMES PHARMACEUTIQUES ORALES<br />

COMPORTANT UNE FORTE DOSE D'UN<br />

PROMÉDICAMENT DE GABAPENTINE<br />

(71) XenoPort, Inc., 3410 Central Expressway,<br />

Santa Clara, CA 95051, US<br />

(72) KARABORNI, Sami, Cupertino, California<br />

95014, US<br />

KIDNEY, David J., San Jose, California<br />

95112, US<br />

MAURER, Laura E., Sunnyvale, California<br />

94086, US<br />

(74) Wytenburg, Wilhelmus Johannes, et al,<br />

Mewburn Ellis LLP 33 Gutter Lane, GB-<br />

London EC2V 8AS, GB<br />

(51) A61K 9/16 (11) 2 403 482 A1*<br />

A61P 25/04 A61K 31/437<br />

A61K 31/4468<br />

(25) En (26) En<br />

(21) 10711246.8 (22) <strong>02</strong>.03.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

AL BA ME RS<br />

(86) GB 2010/000374 <strong>02</strong>.03.2010<br />

(87) WO 2010/100414 2010/36 10.09.2010<br />

(30) 04.03.2009 PCT/GB2009/000592<br />

(54) • GEGEN MISSBRAUCH WIDERSTANDS-<br />

FESTE FORMULIERUNG<br />

• ABUSE RESISTANT FORMULATION<br />

• FORMULATION PERMETTANT D'EMPÊ-<br />

CHER UNE CONSOMMATION ABUSIVE<br />

(71) Orexo AB, Box 303, 751 05 Uppsala, SE<br />

(72) BREDENBERG, Susanne, S-751 05 Uppsala,<br />

SE<br />

DAHLGREN, Anna, S-751 05 Uppsala, SE<br />

SÄGSTRÖM, Anders, S-751 05 Uppsala, SE<br />

ENGQVIST, Hakan, SE-751 23 Uppsala, SE<br />

(74) McNeeney, Stephen Phillip, Potter Clarkson<br />

LLP Park View House 58 The Ropewalk,<br />

Nottingham NG1 5DD, GB<br />

(51) A61K 9/16 (11) 2 403 483 A2*<br />

A61K 9/51 A61K 9/00<br />

A61L 24/00 A61L 24/04<br />

A61L 24/06 A61L 27/16<br />

A61L 27/18 A61L 27/26<br />

A61L 27/54 A61L 31/04<br />

A61L 31/06 A61L 31/16<br />

A61L 31/18<br />

(25) En (26) En<br />

(21) 10712507.2 (22) <strong>02</strong>.03.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) IB 2010/000693 <strong>02</strong>.03.2010<br />

(87) WO 2010/100564 2010/36 10.09.2010<br />

(88) 21.07.2011<br />

(30) <strong>02</strong>.03.2009 US 156737 P<br />

(54) • INJIZIERBARES BIOLOGISCHES MATE-<br />

RIAL<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

• INJECTABLE BIOMATERIAL<br />

• BIOMATÉRIAU INJECTABLE<br />

(71) Assistance Publique Hôpitaux De Paris, 3<br />

Avenue Victoria, 75004 Paris, FR<br />

(72) BAYLATRY, Minh Tam, F-75013 Paris, FR<br />

BISDORF-BRESSON, Anouk, F-75010 Paris,<br />

FR<br />

LABARRE, Denis, F-91140 Villebon Sur<br />

Yvette, FR<br />

LAURENT, Alexandre, F-92400 Courbevoie,<br />

FR<br />

MOINE, Laurence, F-92210 Saint Cloud, FR<br />

SAINT-MAURICE, Jean-Pierre, F-94110<br />

Arcueil, FR<br />

SLIMANI, Khelil, F-92350 Le Plessis Robinson,<br />

FR<br />

WASSEF, Michel, F-75005 Paris, FR<br />

(74) Noel, Chantal Odile, et al, Cabinet Orès 36,<br />

rue de St Pétersbourg, 75008 Paris, FR<br />

A61K 9/16 → (51) A61K 31/64<br />

(51) A61K 9/19 (11) 2 403 484 A2*<br />

(25) En (26) En<br />

(21) 10714064.2 (22) 03.03.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) HU 2010/000<strong>02</strong>5 03.03.2010<br />

(87) WO 2010/100514 2010/36 10.09.2010<br />

(88) 28.10.2010<br />

(30) 03.03.2009 US 612092 P<br />

29.09.2009 HU 0900614<br />

(54) • PHARMAZEUTISCHE ZUSAMMENSET-<br />

ZUNG MIT EINEM FERMENTIERTEN<br />

DEHYDRIERTEN MATERIAL MIT AMOR-<br />

PHER KRISTALLINER STRUKTUR<br />

• PHARMACEUTICAL COMPOSITION CON-<br />

TAINING A FERMENTED, DEHYDRATED<br />

MATERIAL WITH AMORPHOUS CRYS-<br />

TALLINE STRUCTURE<br />

• COMPOSITION PHARMACEUTIQUE<br />

CONTENANT UNE MATIÈRE DÉSHYDRA-<br />

TÉE, FERMENTÉE AVEC UNE STRUCTURE<br />

CRISTALLINE AMORPHE<br />

(71) Hidvégi, Maté, Heged s Gyula u. 63, 1133<br />

Budapest, HU<br />

(72) Hidvégi, Maté, 1133 Budapest, HU<br />

(74) Marmarosi, Tamasné, Ybl Miklós sétány, 19,<br />

2051 Biatorbágy, HU<br />

(51) A61K 9/20 (11) 2 403 485 A2*<br />

A61K 31/205 A61P 25/16<br />

(25) En (26) En<br />

(21) 10706259.8 (22) 04.03.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

AL BA ME RS<br />

(86) EP 2010/052744 04.03.2010<br />

(87) WO 2010/10<strong>02</strong>19 2010/36 10.09.2010<br />

(88) 11.08.2011<br />

(30) 05.03.2009 IN MU04782009<br />

(54) • PHARMAZEUTISCHE ZUSAMMENSET-<br />

ZUNG MIT RASAGILINMESYLAT<br />

• PHARMACEUTICAL COMPOSITION CON-<br />

TAINING RASAGILINE MESYLATE<br />

• COMPOSITION PHARMACEUTIQUE<br />

CONTENANT DU MESYLATE DE RASAGI-<br />

LINE<br />

(71) Sandoz AG, Lichtstrasse 35, 4056 Basel, CH<br />

(72) TALASILA, Kamalakar, Thane 400 607, IN<br />

NARKHEDE, Hemant, Thane 400 607, IN<br />

DAROI, Atul, Thane 400 607, IN<br />

(74) Wichmann, Hendrik, Wuesthoff & Wuesthoff<br />

<strong>Patent</strong>- und Rechtsanwälte Schweigerstraße<br />

2, 81541 München, DE<br />

36<br />

Anmeldungen<br />

Applications<br />

Demandes (<strong>02</strong>/<strong>2012</strong>) 11.01.<strong>2012</strong><br />

(51) A61K 9/20 (11) 2 403 486 A1*<br />

A61K 31/197 A61K 31/27<br />

(25) En (26) En<br />

(21) 10708059.0 (22) 03.03.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

AL BA ME RS<br />

(86) US 2010/<strong>02</strong>6133 03.03.2010<br />

(87) WO 2010/1<strong>02</strong>071 2010/36 10.09.2010<br />

(30) 03.03.2009 US 157114 P<br />

(54) • ORALE DOSIERFORMEN EINES R-BACL-<br />

OFEN-PRODRUGS MIT VERZÖGERTER<br />

FREISETZUNG<br />

• SUSTAINED RELEASE ORAL DOSAGE<br />

FORMS OF AN R-BACLOFEN PRODRUG<br />

• FORMES POSOLOGIQUES ORALES À<br />

LIBÉRATION ENTRETENUE D'UN PROMÉ-<br />

DICAMENT DE R-BACLOFÈNE<br />

(71) XenoPort, Inc., 3410 Central Expressway,<br />

Santa Clara, CA 95051, US<br />

(72) EDGREN, David, E., Los Altos, CA 94<strong>02</strong>2, US<br />

KIDNEY, David, J., San Jose, CA 95112, US<br />

PARGAONKAR, Nikhil, Sunnyvale, CA 94086,<br />

US<br />

KIM, Derrick, K., Issaquah, WA 98<strong>02</strong>7, US<br />

YODER, Gorm, Oakland, CA 94611, US<br />

KARABORNI, Sami, Cupertino, CA 95014, US<br />

(74) Wytenburg, Wilhelmus Johannes, et al,<br />

Mewburn Ellis LLP 33 Gutter Lane, London<br />

EC2V 8AS, GB<br />

(51) A61K 9/20 (11) 2 403 487 A2*<br />

(25) En (26) En<br />

(21) 10740752.0 (22) <strong>02</strong>.03.2010<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) IN 2010/000121 <strong>02</strong>.03.2010<br />

(87) WO 2010/100657 2010/36 10.09.2010<br />

(88) 18.08.2011<br />

(30) 04.03.2009 IN MU04682009<br />

(54) • ORALE DARREICHUNGSFORMEN MIT<br />

VERZÖGERTER FREISETZUNG FÜR WAS-<br />

SERLÖSLICHE ARZNEIMITTEL<br />

• ORAL CONTROLLED RELEASE DOSAGE<br />

FORMS FOR WATER SOLUBLE DRUGS<br />

• NOUVELLES FORMES GALÉNIQUES ORA-<br />

LES À LIBÉRATION CONTRÔLÉE POUR<br />

MÉDICAMENTS HYDROSOLUBLES<br />

(71) Fdc Limited, 142-48, S.V. Road Jogeshwari<br />

(W) Mumbai-400 1<strong>02</strong>, Maharashtra, IN<br />

(72) CHANDAVARKAR, Mohan, Anand, Maharashtra,<br />

IN<br />

JINDAL, Kour, Chand, Maharashtra, IN<br />

MALAYANDI, Rajkumar, Tirupur (DT) 642<br />

154, IN<br />

(74) Murray, Adrian D'Coligny, W.P. Thompson &<br />

Co. 55 Drury Lane, London WC2B 5SQ, GB<br />

A61K 9/20 → (51) A61K 9/00<br />

A61K 9/20 → (51) A61K 9/16<br />

A61K 9/20 → (51) A61K 9/22<br />

A61K 9/20 → (51) A61K 31/551<br />

A61K 9/20 → (51) A61K 31/64<br />

(51) A61K 9/22 (11) 2 403 488 A2*<br />

A61K 9/20 A61K 47/48<br />

A61K 47/34<br />

A61P 27/<strong>02</strong><br />

A61K 47/30<br />

(25) En (26) En<br />

(21) 10749383.5 (22) 05.03.2010

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!